INTERNATIONAL SOCIETY OF ONCOLOGY AND BIOMARKERSActive
Key figures
INTERNATIONAL SOCIETY OF ONCOLOGY AND BIOMARKERS does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2022/23–2024/25
| 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|
| Profit for the year | -66,536 | -38,361 | -36,178 |
| Cash at bank and in hand | 608,808 | 570,697 | 534,749 |
| Total assets | 608,808 | 570,697 | 534,749 |
| Total liabilities | 4,350 | 4,600 | 4,830 |
| Net assets / total equity | 604,458 | 566,097 | 529,919 |
| Average number of employees | 1 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: INTERNATIONAL SOCIETY OF ONCOLOGY AND BIOMARKERS
Company
INTERNATIONAL SOCIETY OF ONCOLOGY AND BIOMARKERS is a private company limited by guarantee registered with Companies House under company number SC469359. It was incorporated on 6 Feb 2014. Its status is active. The registered office is in Forfar (DD8). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Loss for the year was £36,178. Net assets were £529,919, down 6.4% on the previous year. Cash at bank and in hand was £534,749. Total assets were £534,749 and total liabilities £4,830. The company had an average of 0 employees. Figures are available for 3 financial years (2022/23–2024/25).
Filing deadlines
The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 20 Feb 2027.